article thumbnail

Drug Channels News Roundup, October 2021: PBMs’ Oncology Exclusions, Biosimilar Boom, BCBS vs. Hospitals, U.S. vs. the World, and CRISPR Comedy

Drug Channels

Recent posts have covered: Walgreens’ new direction; controversary over independent pharmacy counting; insurer consolidation; retail pharmacy M&A; drug pricing policy; Prime Therapeutics; 340B contract pharmacy litigation; pharmaceutical antitrust; oncology care model; and Peter Bach’s nuptials.

article thumbnail

Beyond the Big Three PBMs: Examining a Potential Trend

Perficient: Drug Development

Key players, including drug manufacturers, independent pharmacies, and physicians, find themselves navigating an intricate web of issues, and the repercussions ultimately impact the most vulnerable stakeholders: patients. This ongoing struggle contributes to the broader atmosphere of tension within the pharmaceutical sector.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

AHF Cheers Supreme Court ‘Rutledge’ Ruling Allowing States to Regulate PBMs

The Pharma Data

Pharmaceutical Care Management Association , the Court recognized that state legislatures have important powers to regulate abuses of corporate healthcare middlemen, called Pharmacy Benefit Managers (PBMs). “In This predatory practice has driven independent pharmacies out of business, to the harm of the patients they serve.”.

article thumbnail

Flu jabs limited due to high demand

The Pharma Data

The Royal Pharmaceutical Society (RPS) says other independent pharmacies have also had to slow down the rate of vaccination. Robbie Turner, RPS Director of Pharmacy, said: “This year many more people are anticipating receiving a flu vaccination and they need assurance that sufficient stocks are available.